Skip to main content
Top
Published in: Sleep and Breathing 2/2009

Open Access 01-05-2009 | Original Article

Prevalence of Cheyne–Stokes respiration in modern treated congestive heart failure

Authors: Gerrit Hagenah, Dennis Beil

Published in: Sleep and Breathing | Issue 2/2009

Login to get access

Abstract

Introduction

The prevalence of sleep breathing disorders in patients with congestive heart failure is relevantly high. According to historical studies Cheyne–Stokes respiration is an oscillatory ventilation during sleep in up to 40% of patients with congestive heart failure. During the last decade the medical treatment of congestive heart failure has been improved. The aim of this investigation was to analyze the prevalence of Cheyne–Stokes respiration in patients with congestive heart failure and modern medical treatment.

Results and discussion

In 50 patients with severe congestive heart failure receiving modern medical treatment a full night polysomnography was performed. All patients had ß-blockers and angiotensin-converting-enzyme inhibitors or angiotensin-II-antagonists as standard treatment. The mean age was 63 ± 12 years and the mean left ventricular ejection fraction was 26 ± 6%. Respiratory polygraphy revealed Cheyne–Stokes respiration with a respiratory disturbance index of ≥5/h sleep in 32 (64%) of the seven female and 43 male patients. The prevalence of Cheyne–Stokes respiration defined by using the threshold of an apnea index of ≥10/h was 30%.

Conclusion

Thus, no significant change of Cheyne–Stokes prevalence could be found in our modern treated severe congestive heart failure collective.
Literature
1.
go back to reference Findley LJ, Zwillich CW, Anconi-Israel S, Kripke D, Moser KM (1985) Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 78(1):11–15PubMed Findley LJ, Zwillich CW, Anconi-Israel S, Kripke D, Moser KM (1985) Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 78(1):11–15PubMed
2.
go back to reference Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed
3.
go back to reference Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1077–1078 Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1077–1078
4.
go back to reference Cheyne J (1818) A case of apoplexy in which the fleshy part of the heart is turned to fat. Dublin Hosp Rep 2:216–223 Cheyne J (1818) A case of apoplexy in which the fleshy part of the heart is turned to fat. Dublin Hosp Rep 2:216–223
5.
go back to reference Stokes W (1854) The diseases of the heart and the aorta. Hodges and Smith, Dublin, pp 323–326 Stokes W (1854) The diseases of the heart and the aorta. Hodges and Smith, Dublin, pp 323–326
6.
go back to reference Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed Hanly PJ, Zuberi-Khokhar NS (1996) Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153(1):272–276PubMed
7.
go back to reference Lanfranchi PA, Braghiroli A, Bosimini E, Mazzero G, Colombo R, Donner CF et al (1999) Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99(11):1435–1440PubMed Lanfranchi PA, Braghiroli A, Bosimini E, Mazzero G, Colombo R, Donner CF et al (1999) Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99(11):1435–1440PubMed
10.
go back to reference Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. AASM Manual for Scoring Sleep Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. AASM Manual for Scoring Sleep
11.
go back to reference American Academy of Sleep Medicine (2005) ICSD-2 International classification of sleep disorders, 2nd edn: Diagnostic and coding manual. Westchester, Illinois, USA American Academy of Sleep Medicine (2005) ICSD-2 International classification of sleep disorders, 2nd edn: Diagnostic and coding manual. Westchester, Illinois, USA
14.
go back to reference Gruppo Italiano per lo Studio della Sopravvivenza nell Infarcto Miocardico (1994) GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115–1122 Gruppo Italiano per lo Studio della Sopravvivenza nell Infarcto Miocardico (1994) GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115–1122
15.
go back to reference Cohn JN, Tognoni G (2001) Valsartan heart failure trial investigators: a randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667–1675 doi:10.1056/NEJMoa010713 PubMedCrossRef Cohn JN, Tognoni G (2001) Valsartan heart failure trial investigators: a randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345:1667–1675 doi:10.​1056/​NEJMoa010713 PubMedCrossRef
16.
go back to reference The SOLVD Investigators (1991) effect of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302 The SOLVD Investigators (1991) effect of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302
19.
go back to reference Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ et al (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure. A randomised trial—the losartan heart failure survival study ELITE II. Lancet 355:1582–1587 doi:10.1016/S0140-6736(00)02213-3 PubMedCrossRef Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ et al (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure. A randomised trial—the losartan heart failure survival study ELITE II. Lancet 355:1582–1587 doi:10.​1016/​S0140-6736(00)02213-3 PubMedCrossRef
20.
go back to reference Walsh JT, Andrews R, Starling R, Starling AJ, Johnston ID, Kinnear WJ (1995) Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 73(3):237–241 doi:10.1136/hrt.73.3.237 PubMedCrossRef Walsh JT, Andrews R, Starling R, Starling AJ, Johnston ID, Kinnear WJ (1995) Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 73(3):237–241 doi:10.​1136/​hrt.​73.​3.​237 PubMedCrossRef
23.
go back to reference Kinsman TA, Townsend NE, Gore CJ, Hahn AG, Clark SA, Aughey RJ et al (2005) Sleep disturbance at simulated altitude indicated by stratified respiratory disturbance index but not hypoxic ventilatory response. Eur J Appl Physiol 94:569–575 doi:10.1007/s00421-005-1368-6 PubMedCrossRef Kinsman TA, Townsend NE, Gore CJ, Hahn AG, Clark SA, Aughey RJ et al (2005) Sleep disturbance at simulated altitude indicated by stratified respiratory disturbance index but not hypoxic ventilatory response. Eur J Appl Physiol 94:569–575 doi:10.​1007/​s00421-005-1368-6 PubMedCrossRef
Metadata
Title
Prevalence of Cheyne–Stokes respiration in modern treated congestive heart failure
Authors
Gerrit Hagenah
Dennis Beil
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2009
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-008-0218-2

Other articles of this Issue 2/2009

Sleep and Breathing 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.